Also Read | Russia tests Covid vaccine as nasal spray for children; to be ready by mid-Sept“I think our preliminary assessment indicates that vaccines will require a dedicated manufacturing facility and it cannot be produced in a facility where we are making multiple other products," Sun Pharmaceutical Industries Managing Director Dilip Shanghvi said in a call with analysts.The billionaire industrialist noted that for getting into vaccine production, a completely new set of manufacturing infrastructure is required.“So, that's broadly our understanding.
So, we currently don't have any facility which we are looking at for producing vaccines," Shanghvi said.Also Read | Bangladesh to buy Chinese vaccines for undisclosed priceOn the biosimilar.